Judy Buelke‐Sam - Concepedia

Author

Judy Buelke‐Sam

Eli Lilly (United States)

Also Known As

Judy BUELKE‐SAM, Judy Buelke-Sam, Judy Buelke‐Sam, Judy L Buelke-Sam, Judy L. Buelke‐Sam, Raef Haddad

Publications

321

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)

About

Judy Buelke‐Sam is an author at Eli Lilly (United States) specializing in medicine, toxicology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	143
2	Public Health	3	3	66
3	Endocrinology	3	3	49
4	Obstetrics	3	3	76
5	Social Sciences	1	1	53

Judy Buelke‐Sam

Publications

143

Citations

H-Index

Page 1

	Year	Citations
Development and standardization of screening methods for behavioral teratology Judy Buelke‐Sam, Carole A. Kimmel Teratology DiagnosisToxicology TestingBehavioral ScreenSocial SciencesPre-clinical Pharmacology	1979	53
Communicating risks during pregnancy: A workshop on the use of data from animal developmental toxicity studies in pregnancy labels for drugs Anthony R. Scialli, Judy Buelke‐Sam, Christina Chambers, Birth Defects Research Part A Clinical and Molecular Teratology Drug SafetyPregnancy LabelsEarly Life ExposureDevelopmental ToxicologyReproductive Health	2004	41
The Selective Estrogen Receptor Modulator, Raloxifene: A Segment II/III Delivery Study in Rats 11This study (except for immune system assessments) was conducted in accordance with the FDA’s Good Laboratory Practices for Nonclinical Laboratory Studies [1]. Judy Buelke‐Sam, Ilene R. Cohen, Daniel Wierda, Reproductive Toxicology Molecular PharmacologyImmune System AssessmentsMedicineHormonal ReceptorUterine Receptivity	1998	24
The Selective Estrogen Receptor Modulator, Raloxifene: Reproductive Assessments following Premating Exposure in Female Rats 11These studies were conducted in accordance with the Food and Drug Administration “Good Laboratory Practice Regulations for Nonclinical Laboratory Studies.” CRF Part 58, 1978. J A Hoyt, Lawrence F. Fisher, Judy Buelke‐Sam, Reproductive Toxicology FertilityReproductive HealthFemale Reproductive FunctionReproductive BiologyReproductive Epidemiology	1998	14
The Selective Estrogen Receptor Modulator, Raloxifene: Reproductive Assessments Following Preimplantation Exposure in Mated Female Rats 11These studies were conducted in accordance with the Food and Drug Administration “Good Laboratory Practice Regulations for Nonclinical Laboratory Studies.” CRF Part 58, 1978. David O. Clarke, Kelly I. Griffey, Judy Buelke‐Sam, Reproductive Toxicology FertilityFemale InfertilityPreimplantation ExposureMedicineUterine Receptivity	1998	11

Page 1